Press Releases about POLBF
Via TheNewswire.com
Via ACCESSWIRE
Poolbeg Pharma PLC Announces Board Appointment
May 24, 2023
Via ACCESSWIRE
Via ACCESSWIRE
Poolbeg Pharma PLC Announces Annual Report & AGM Notice
April 12, 2023
Via ACCESSWIRE
Via TheNewswire.com
Via ACCESSWIRE
Via TheNewswire.com
Via TheNewswire.com
Via TheNewswire.com
Poolbeg Pharma announces expansion of POLB 001 into oncology
January 18, 2023
Via TheNewswire.com
Topics
Intellectual Property
Exposures
Intellectual Property
Via ACCESSWIRE
Poolbeg Identifies Novel RSV Drug Candidates
December 21, 2022
Via ACCESSWIRE
Via ACCESSWIRE
Poolbeg Pharma PLC - POLB 001 LPS Human Challenge Trial Completed
December 12, 2022
Via ACCESSWIRE
Poolbeg Pharma PLC Announces Influenza AI model build completed
November 29, 2022
Via ACCESSWIRE
Poolbeg Pharma PLC Announces Capital Markets Day
November 17, 2022
Via ACCESSWIRE
Poolbeg-led Consortium Awarded EUR 2.3m Grant
November 15, 2022
Via ACCESSWIRE
Poolbeg Pharma PLC Announces AI Programme Yields Novel RSV Drug Targets
November 08, 2022
Via ACCESSWIRE
Poolbeg Pharma PLC Announces CEO Share Purchase
October 06, 2022
Via ACCESSWIRE
Poolbeg Pharma PLC Announces POLB 001 US Patent update
October 04, 2022
Via ACCESSWIRE
Poolbeg Licence of Melioidosis Vaccine Candidate
September 21, 2022
Via ACCESSWIRE
Poolbeg Pharma PLC Announces HC Wainwright Global Investment Conference
September 12, 2022
Via ACCESSWIRE
Poolbeg Pharma PLC Announces Appointment of Joint Broker
July 29, 2022
Via ACCESSWIRE
Poolbeg Pharma PLC Announces Appointment of Joint Broker
July 29, 2022
From Poolbeg Pharma PLC
Via AccessWire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.